Faisal Zain is a leading authority in medical technology and healthcare logistics, currently steering the strategic direction of Cardinal Health’s largest Latin American market. With a career dedicated to bridging the gap between manufacturing innovation and clinical application, he has become a pivotal figure in transforming how essential medical supplies are delivered and utilized in complex emerging markets. In this conversation, we explore the delicate balance between public sector availability and private sector innovation, the shift from viewing medical supplies as commodities to clinical solutions, and the digital transformation of the Mexican healthcare supply chain.
We delve into the specific strategies used to prioritize high-impact clinical areas like DVT prophylaxis and enteral nutrition, the importance of clinical education in the adoption of global safety standards, and the operational agility required to navigate a market that represents a quarter of the region’s healthcare business.
Mexico represents a quarter of the healthcare business across Latin America. How are you currently prioritizing specific clinical areas like DVT prophylaxis and enteral nutrition, and what specific metrics do you use to evaluate the success of these specialized segments?
Mexico is our most significant market in the region, and we focus our energy on three key pillars: DVT prophylaxis, enteral nutrition, and the transition to powder-free surgical gloves. We don’t just look at sales volume; we prioritize leadership in prevention and the scaling of safe delivery systems. Success is measured by our ability to move the market toward these higher standards, ensuring that our 25% share of the Latin American business translates into measurable improvements in patient safety. We track the adoption rates of our specialized portfolios, particularly how many institutions are moving away from traditional methods toward our technologically advanced, accurate delivery systems.
Managing direct relationships with private hospitals while coordinating a broad distributor network requires immense oversight. How do you ensure that local partners maintain strict compliance and ethical standards while navigating the logistical complexities of reaching institutions across the entire country?
Maintaining a hybrid strategy is a complex balancing act, but it is the only way to ensure we reach the 70% of private hospitals where we currently have a presence. Our distributors are more than just logistics providers; they are commercial partners who must mirror our own rigorous ethical and compliance frameworks. We invest heavily in continuous training for these partners to ensure that every interaction they have with a hospital aligns with our global standards. It is a matter of disciplined execution where we combine our internal operational excellence with the local reach of our partners to guarantee that quality is never sacrificed for geographic coverage.
Essential supplies like surgical gloves and catheters are often viewed as simple commodities. How does your team integrate clinical education and technical support into the delivery process to demonstrate the long-term operational value and safety benefits of transitioning to higher-standard, powder-free products?
The “commodity” label is something we actively fight against by embedding technology and clinical value into every item, whether it’s a compression stocking or a urology catheter. Our approach is built on the belief that adoption does not end when the box is delivered; it begins there through constant engagement with nursing and epidemiology teams. For instance, while powdered gloves are still used in parts of Latin America, we use clinical education to explain the safety risks that led to their ban in other global markets. By providing continuous technical support and evidence-based training, we help hospital administrators see that high-quality, powder-free options are an investment in better patient outcomes rather than just an expense.
Public sector demand often involves rapid tender timelines and a high risk of product shortages. What specific forecasting techniques or inventory management strategies allow you to anticipate these urgent needs without compromising the innovation-focused approach required by the private healthcare sector?
In the public sector, the priority is absolute availability, which often requires us to work backward from a one-month delivery window mandated by a tender. To manage this, we have moved from a reactive model to an anticipatory one, where we align our internal processes to the rapid pace of local government approvals. We differentiate our inventory strategies: the private sector pulls from an innovation-heavy pipeline, while the public sector relies on a robust, cost-effective supply of essential items. This agility is only possible because we view these market conditions not as barriers, but as the fundamental realities we must adapt to through flexible supply chain planning.
Digital visibility is becoming essential for modern medical logistics. How are you utilizing tools like AI and integrated dashboards to improve forecasting accuracy, and how do digital learning platforms help scale professional certifications for physicians across such a geographically diverse market?
We are currently integrating comprehensive dashboards across our entire logistics operation to link our ERP systems with real-time service level monitoring. These tools are the foundation for our move toward AI-driven management, which we are evaluating to further optimize how we predict demand and manage stock. On the educational side, we’ve moved beyond the limitation of a single trainer visiting one hospital at a time by launching structured digital learning platforms. By collaborating with medical societies, we provide online courses that offer professional certifications to physicians, allowing us to scale high-quality clinical training across Mexico’s vast geography simultaneously.
Global disruptions have highlighted the need for diversified sourcing and strategic buffer stocks. Could you walk through the practical steps taken to build a more resilient infrastructure and explain how end-to-end data sharing helps mitigate risks during periods of extreme market volatility?
Resilience in our supply chain is built on the pillars of diversification and transparency. We have moved away from relying on single-source suppliers, instead maintaining a broad base that allows us to pivot during regional disruptions. Practically, this involves keeping strategic buffer stocks of critical items to act as a shock absorber when volatility spikes. The real secret, however, is end-to-end data sharing; when we have clear visibility from the manufacturing site to the final hospital delivery, we can make faster, more accountable decisions. This integrated information flow reduces risk and ensures that even during global crises, our local service levels remain steady.
Focusing on prevention, such as avoiding surgical complications through better nutrition or glove quality, is often more cost-effective than treatment. How are you collaborating with hospital administrators to shift their focus toward these preventive solutions, and what challenges arise when changing established clinical practices?
The biggest challenge is the traditional healthcare mindset that prioritizes treating problems after they occur rather than preventing them. We address this by sitting down with administrators and presenting the economic case for prevention—showing, for example, how DVT prophylaxis or better enteral nutrition reduces the length of hospital stays and infection rates. We frame prevention as a guiding principle for sustainability; it is objectively more cost-effective to invest in high-quality surgical gloves today than to treat a clinical complication tomorrow. Changing these established practices requires a long-term perspective and a constant presence in the hospital to support clinical teams through the transition.
As you look toward 2026, the goal is to maintain consistent year-over-year growth despite tariff pressures and market disruptions. What is the step-by-step plan for your upcoming product pipeline, and how will you ensure your human resources are prepared to support these new launches?
Our plan for 2026 is rooted in a structured pipeline with clear, phased timelines for bringing new US-standard products into the Mexican market. Following our 10th anniversary, we are entering a phase of aggressive portfolio expansion where human resource readiness is as important as regulatory approval. We are allocating significant resources to ensure our teams are not just salesmen, but clinical experts capable of training hospital staff on every new technology we launch. This requires an integrated regional approach where our Mexican team often leads training initiatives for the rest of Latin America, ensuring that our internal growth keeps pace with our commercial ambitions.
What is your forecast for the evolution of smart supply chains in Mexico?
I believe the future of the Mexican healthcare supply chain lies in the total integration of data between the supplier and the provider. We are moving toward a model where AI doesn’t just manage inventory but predicts clinical needs before the hospital even places an order. As we continue to deploy digital dashboards and scale our educational platforms, the line between a product supplier and a service provider will disappear. Mexico is already becoming a reference market for the region, and by 2030, I expect to see a fully transparent, highly automated ecosystem where product shortages are virtually eliminated through predictive analytics and hyper-local resilience strategies.
